Owned by the Association for International Promotion & Study in Tumors (APSIT)
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
Triple negative breast cancer (TNBC) is an incurable disease where novel therapeutic strategies are needed. Proteolysis targeting chimeric (PROTAC) are novel compounds that promote protein degradation by bindi...